Hongmin Wang Selected Research

Ubiquitins

2/2020	Attenuation of Ischemic Stroke-Caused Brain Injury by a Monoamine Oxidase Inhibitor Involves Improved Proteostasis and Reduced Neuroinflammation.
1/2020	Therapeutic Role of a Cysteine Precursor, OTC, in Ischemic Stroke Is Mediated by Improved Proteostasis in Mice.
10/2017	Enhanced Proteostasis in Post-ischemic Stroke Mouse Brains by Ubiquilin-1 Promotes Functional Recovery.
4/2017	Reduced body weight gain in ubiquilin-1 transgenic mice is associated with increased expression of energy-sensing proteins.
1/2017	Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hongmin Wang Research Topics

Disease

14	Neoplasms (Cancer) 01/2021 - 01/2012
8	Huntington Disease (Huntington's Disease) 11/2017 - 03/2006
7	Ischemic Stroke 01/2021 - 02/2014
7	Stroke (Strokes) 02/2020 - 02/2014
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 03/2006
4	Brain Injuries (Brain Injury) 01/2021 - 10/2017
4	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2012
3	Neuroinflammatory Diseases 01/2021 - 01/2020
3	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 04/2014
3	Ovarian Neoplasms (Ovarian Cancer) 10/2019 - 01/2019
3	Reperfusion Injury 12/2018 - 07/2002
3	Lung Neoplasms (Lung Cancer) 01/2016 - 07/2014
2	Liver Failure 09/2022 - 01/2022
2	Infarction (Infarctions) 01/2021 - 01/2018
2	Ischemia 01/2021 - 10/2017
2	Pneumonia (Pneumonitis) 01/2021 - 07/2018
2	Brain Ischemia (Cerebral Ischemia) 01/2018 - 10/2017
2	Body Weight (Weight, Body) 04/2017 - 09/2013
2	Lymphatic Metastasis 10/2015 - 01/2012
2	Colonic Neoplasms (Colon Cancer) 09/2015 - 01/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015 - 01/2013
1	Inflammation (Inflammations) 12/2022
1	Sepsis (Septicemia) 12/2022
1	Infections 12/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2022
1	Acute-On-Chronic Liver Failure 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021
1	Adenocarcinoma of Lung 10/2020
1	Heart Diseases (Heart Disease) 01/2020
1	Dementia (Dementias) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2019
1	Atherosclerosis 07/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2018
1	Cardiomyopathies (Cardiomyopathy) 12/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2018

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2006
5	UbiquitinsIBA 02/2020 - 01/2017
5	polyglutamineIBA 11/2012 - 03/2006
4	CytokinesIBA 01/2020 - 03/2015
4	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2018 - 04/2014
3	Protein AggregatesIBA 01/2021 - 01/2017
3	Amyloid (Amyloid Fibrils)IBA 01/2020 - 01/2017
3	Oncogene Proteins (Oncogene Protein)IBA 03/2016 - 01/2015
2	AcidsIBA 01/2021 - 08/2019
2	MicroRNAs (MicroRNA)IBA 10/2020 - 01/2014
2	Opioid Receptors (Opioid Receptor)IBA 01/2020 - 01/2018
2	celastrolIBA 10/2019 - 01/2019
2	Polysaccharides (Glycans)IBA 09/2014 - 07/2014
2	Glutamic Acid (Glutamate)FDA Link 12/2003 - 07/2002
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022
1	Crystallins (Crystallin)IBA 01/2021
1	Small Heat-Shock ProteinsIBA 01/2021
1	SilymarinIBA 01/2021
1	flavoneIBA 01/2021
1	Amino Acids FDA Link 01/2021
1	Transaminases (Aminotransferases)IBA 01/2021
1	CarbohydratesIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	NucleotidesIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021
1	Interleukin-13IBA 01/2021
1	PhytochemicalsIBA 01/2021
1	Untranslated RNA (Noncoding RNA)IBA 10/2020
1	Competitive Endogenous RNAIBA 10/2020
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	Monoamine Oxidase (MAO)IBA 02/2020
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 02/2020
1	Interleukin-4 (Interleukin 4)IBA 01/2020
1	Glutathione (Reduced Glutathione)IBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2020
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	Superoxides (Superoxide)IBA 01/2020
1	Conditioned Culture MediaIBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Macrophage Colony-Stimulating FactorIBA 01/2020
1	cinnamamideIBA 10/2019
1	Biological ProductsIBA 10/2019
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 07/2019
1	Free RadicalsIBA 07/2019
1	Silicon Dioxide (Silica)FDA LinkGeneric 07/2019
1	QuercetinIBA 07/2019
1	Ubiquitinated ProteinsIBA 12/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2018
1	naltrindoleIBA 01/2018
1	TAN 67IBA 01/2018
1	Vitamin B Complex (B Vitamins)IBA 05/2017
1	HomocysteineIBA 05/2017
1	Insulin (Novolin)FDA Link 04/2017
1	LeptinIBA 04/2017

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 10/2019 - 09/2015
3	Therapeutics 10/2019 - 11/2014
2	Transplantation 12/2022 - 01/2021
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2022 - 01/2021
1	Hematopoietic Stem Cell Transplantation 12/2022
1	Liver Transplantation 09/2022
1	Secondary Prevention 05/2017